Pluri Inc (PLUR)
4.560
-0.29
(-5.98%)
USD |
NASDAQ |
Nov 04, 16:00
4.85
+0.29
(+6.36%)
After-Hours: 20:00
Pluri Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2019 | 95.65% |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 96.00% |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 96.00% |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 96.48% |
Date | Value |
---|---|
September 30, 2015 | 96.84% |
June 30, 2015 | 96.81% |
March 31, 2015 | 96.84% |
December 31, 2014 | 95.79% |
September 30, 2014 | 96.84% |
June 30, 2014 | 97.87% |
March 31, 2014 | 96.84% |
December 31, 2013 | 96.84% |
September 30, 2013 | 96.84% |
June 30, 2013 | 97.89% |
March 31, 2013 | 96.91% |
December 31, 2012 | 96.92% |
September 30, 2012 | 96.92% |
June 30, 2012 | 97.03% |
March 31, 2012 | 97.39% |
December 31, 2011 | 96.97% |
September 30, 2011 | 96.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
95.65%
Minimum
Dec 2019
95.65%
Maximum
Dec 2019
95.65%
Average
95.65%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
InspireMD Inc | 19.03% |
IDenta Corp | 69.38% |
BiomX Inc | -- |
IR-Med Inc | -- |
Raphael Pharmaceutical Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -259.7% |
Return on Assets | -49.07% |
Return on Invested Capital | -65.52% |
Profit Margin (Quarterly) | -5.97K% |
Operating Margin (Quarterly) | -6.29K% |
Return on Net Operating Assets | -250.5% |